THE IMPACT OF AGRICULTURAL BIOTECHNOLOGY ON ENVIRONMENTAL AND FOOD SECURITY RISK ANALYSIS AND BIOSAFETY OF GMOS Dr. Moisés Burachik Secretariat of Agriculture,

Slides:



Advertisements
Similar presentations
SCIENCE,SUSTAINABLE AGRICULTURE AND RURAL DEVELOPMENT IN THE E.U.
Advertisements

Pest Risk Analysis (PRA) Training
Cartagena Protocol on Biosafety -Reducing the Environmental Risks of Modern Biotechnology Secretariat of the Convention on Biological Diversity
GENETICALLY MODIFIED FOODS
NDSU Agriculture NDSU Policy on Biotech Research & GM Wheat Update Duane Hauck Assistant Director – Ag & Natural Resources NDSU Extension Service.
Transgenic rice and biosafety procedures D.S. Brar PGPB, IRRI Rice Production Course.
Food Inc.. Warm up Discuss at your table: Have you eaten any GMO (genetically modified organisms) food today?
ENVIRONMENT SAFETY: RISK ASSESSMENT AND MONITORING Clarito M. Barron, CESO IV Assistant Director, BPI and Chair, DA-BPI Biotechnology Core Team.
Introduction to Regulatory Affairs: Agencies and Permit Process Advanced Biotechnology (c)(8)(A)
Current Perspectives on Biotechnology: Projects and Future Challenges/Opportunities Jordan BeanDr. Jaimie Schnell Novel Foods SectionPlant Health and Biotechnology.
The International Regulation of Biotechnology Lecture No. 19 Further Inf. For further information and video link please click on the right buttons in the.
Regulation and Safety Assessment of Novel Foods in Canada William Yan, Ph.D. Office of Food Biotechnology Health Canada.
Safety and Regulation in Agricultural Biotechnology MUPGRET Workshop.
BIOSAFETY CONCERNS IN THE CONTEXT OF BIOTECHNOLOGY. Presentation for Training Workshop for Regional Advisors Bangkok, Thailand May 2006.
FDA’s Policy for Evaluating Bioengineered Foods Jeanette Glover Glew Food and Drug Administration Center For Food Safety and Applied Nutrition September,
A Study of Genetically Modified Crops: Their Advantages and Disadvantages Prepared by: Matthew MacMullin, Biological Engineering Jordan Smith, Food Science.
Biosafety and recombinant DNA technology. Involves.... Experiments involving the construction or use of GMOs should be conducted after performing a biosafety.
Genetically engineered foods: a threat to human health? Encontro de Investigadores, Ciência 2009 Rita Batista.
Genetically Modified Organisms in Agricultural Production.
Consistency of SEC assessment under the Cartagena Protocol with other international obligations Karinne Ludlow, Monash University, Australia
Data Requirements for Field Release and Monitoring Jon Knight Imperial College London
Risk assessment: Bt corn MON810 Risk assessment: identifying and evaluating possible dangers predicting the chances the danger will occur assessing the.
NATIONAL CAPACITY FOR EVALUATION OF EVIDENCE AND DECISION-MAKING Mauro Toledo Marrelli Universidade de São Paulo.
Regulatory Procedure for the Assessment of GM Foods.
AP Biology Ch. 20 Biotechnology.
Agricultural Biotechnology: The Technology in the Seed Drew L. Kershen Earl Sneed Centennial Law Professor University of Oklahoma Copyright 2001, all rights.
Exploring Biotechnology & GMOs
Ole Kr. Fauchald Introduction to biodiversity n What is ”biodiversity”? ä Distinguish between levels of biodiversity ä Development of biodiversity.
An Introduction to CPB and Importance of BCH to CPB Obligations.
Biotechnology and Genetic Engineering. Human Cloning-The Science In The News.
Overview of the USDA Biotechnology Risk Assessment Grants Program Deb Hamernik, PhD National Program Leader, Animal Physiology US Department of Agriculture.
Genetic Engineering. What Do These Items Have In Common?
Characterization, Inventory and Monitoring of trends in indigenous livestock Dr. E. D. Ilatsia D. N. Kamiti 23-Oct-15Animal Breeding and Genomics Group1.
Genetically Modified Foods. What is GMO’s Genetically modified organisms.
ENVR 401 December 1, 2003 Supervisor: George McCourt Ashleigh Akalehiywot Andrea Hicks Mara Dacso Ted Walker Lillian Harris Kate Washington Regulation.
Module 3 Risk Analysis and its Components. Risk Analysis ● WTO SPS agreement puts emphasis on sound science ● Risk analysis = integrated mechanism to.
Biotechnology Priorities for South Africa Prof. Diran Makinde AfricaBio Cape Town- 14/15 April 2003.
Codex Science-based Approach to the Safety of Foods Derived from Modern Biotechnology James H. Maryanski, Ph.D. Food and Drug Administration Center for.
Biotechnology Risk Assessment and Risk Reduction Sally McCammon Biotechnology Regulatory Services Animal and Plant Health Inspection Service, USDA.
Guatemala: An evaluation of Biosafety Regulations Drew L. Kershen Earl Sneed Centennial Professor Univ. of Oklahoma, College of Law Copyright 2007, all.
Regulations and Ethics. There are two sides to every issue… Do I look like a Frankenfood?
International Atomic Energy Agency Roles and responsibilities for development of disposal facilities Phil Metcalf Workshop on Strategy and Methodologies.
Modern Day Genetics.
1 DEAT PERSPECTIVE ON GENETICALLY MODIFIED ORGANISMS 31 JULY 2007.
What does it take to bring a GM crop to market? Alan McHughen UC Riverside
Tracy McCracken SPS Technical Advisor East Africa Region United States Agency for International Development (USAID) Kenya and East Aferica/Office of Regional.
What do these labels mean to you?. Have you seen these labels? Are there any food labels that could be misleading or meaningless?
What are GMOs? Some technical background on the genetic modification of plants Stuart Brown Associate Professor NYU School of Medicine.
GENETICALLY MODIFIED ORGANISM (GMO) TECHNOHOLICS.
Genetically Modified Foods. What is a Genetically Modified Food? Foods that contain an added gene sequence Foods that have a deleted gene sequence Animal.
Brechko Susanna, Zimoglyad Anna Form 11 ch/b Lyceum of science Zhovti Vody.
Agricultural Biotechnology in Turkey
Genetically Modified Foods (GMO)
THE NON-BIOLOGICAL FACTORS THAT IMPACT BIOTECH INNOVATION
University of Greenwich
THE ETHICAL ISSUES THAT ARISE FROM THE PRODUCTION OF GMOs
WORKSHOP ON CULTURAL AND RELIGIOUS ISSUES SURROUNDING GMO’S
Stewardship Revision Quiz
IPP Training, IAPSC & IPPC/FAO/FAORAF
Overview of the WTO SPS Agreement and the role of
What do these labels mean to you?
Genetically Modified.
What do these labels mean to you?
Genetically Modified Foods
What do these labels mean to you?
ROLE OF KEPHIS IN SAFE HANDLING, TRANSFER AND USE OF GMOS.
Animal, Plant & Soil Science
The Plant World and Genetic Engineering
Cartagena Protocol on Biosafety -Reducing the Environmental Risks of Modern Biotechnology Secretariat of the Convention on Biological Diversity
What do these labels mean to you?
Presentation transcript:

THE IMPACT OF AGRICULTURAL BIOTECHNOLOGY ON ENVIRONMENTAL AND FOOD SECURITY RISK ANALYSIS AND BIOSAFETY OF GMOS Dr. Moisés Burachik Secretariat of Agriculture, Livestock, Fisheries and Food

SUMMARY  BIOTECHNOLOGY IMPACTS  BIOSAFETY  RISK ANALISIS OF GMOs  RISK ASSESSMENT: DATA REQUIREMENTS FOR REVIEW: - PHENOTYPIC EXPRESSION - MOLECULAR GENETICS  RISK MANAGEMENT  RISK COMMUNICATION  IMPLEMENTATION OF THE REGULATORY FRAMEWORK

BIOTECHNOLOGY IMPACTS

SOME BIOTECHNOLOGY IMPACTS ON AGRICULTURE  DE RECURSOS CROPS CAN BE MODIFIED TO OBTAIN:  INCREASES IN PRODUCTIVITY AND QUALITY OF PRODUCTS  SIMPLIFIED AND IMPROVED AGRICULTURAL PRACTICES  MORE EFFICIENT USE OF RESOURCES  RESISTANCE AGAINST INSECTS, PATHOGENS, ABIOTIC STRESSES  INCREASES IN LAND AVAILABLE TO AGRICULTURE

SPECIAL QUESTIONS RELATED TO GMOS DERIVED FOOD DEVELOPMENT OF REVIEW PROCEDURES AND METHODS FOR FOODSAFETY ASSESSMENT IMPACTS (INCREASES?) IN NUTRITIONAL VALUE NEW USES (MOLECULAR PHARMING, PLASTICS) QUALITY IMPROVEMENT IMPROVED PROCESSING TECHNOLOGIES THERAPEUTIC USES (VACCINES, DRUGS)

AGRICULTURAL BIOTECHNOLOGY ALSO IMPACTS ON THE ENVIRONMENT  BIODIVERSITY PROTECTION  SOCIAL ACCEPTANCE  SUSTAINABILITY  REQUIREMENT OF AN APPROPRIATE REGULATORY FRAMEWORK  HARMONIZATION AND COMPLIANCE WITH INTERNATIONAL AGREEMENTS

AGRICULTURAL BIOTECHNOLOGY HAS IMPACTS ON OTHER OTHER AREAS  HIGH SCIENCE AND TECHNOLOGY CAPACITIES, COSTOS (NEED FOR AUTONOMOUS DEVELOPMENTS)  HIGH CONCENTRATION OF OWNERSHIP - ROYALTIES (INTELLECTUAL PROPERTY RIGHTS)  MARKET SHIFTS (NEW PRODUCERS, DIFFERENT REGULATORY REQUIREMENTS)

BIOSAFETY

BIOSAFETY: ONE DEFINITION CONDITION PROVIDED THROUGH A SET OF MEASURES WITH THE PURPOSE OF THE PROTECTION OF HUMAN, ANIMAL, PLANT AND ENVIRONMENTAL HEALTH, AGAINST KNOWN OR PERCEIVED RISKS OF ANY ACTION, PROJECT OR TECHNIQUE, ACCORDING TO THE BEST OF OUR CURRENT SCIENTIFIC KNOWLEDGE.

BIOSAFETY REQUIRES THE HARMONIZATION OF DIFFERENT INTERESTS SOCIETY (DEMANDING PROTECTION) GOVERNMENT (IN CHARGE OF THE DESIGN AND IMPLEMENTATION OF THE REGULATORY INSTRUMENTS) THE DEVELOPERS OF THE INNOVATIONS (INVEST IN R & D OF NEW PRODUCTS IN THE MARKET AND EXPECT A RETURN IN ORDER TO KEEP THE PROCESS OF PRODUCING FURTHER INNOVATIONS)

BIOSAFETY REQUIRES A COMPLEX AND DYNAMIC REGULATORY FRAMEWORK PROACTIVE (A PROVISIONAL DEFINITION OF THE PRECAUTIONATY APPROACH): –THE REGULATORY FRAMEWORK FOLLOWS ALL ALONG THE DEVELOPMENT OF THE PRODUCT –ANY UNEXPECTED EFFECT IS DETECTED EARLY IN THE DEVELOPMENT AND WILL STOP IT IF ADVISABLE –REASONABLE DOUBTS (COMPLETE SCIENTIFIC DATA ARE NOT NEEDED BUT GAPS SHOULD BE DEFINED ) WILL TRIGGER THE PRECAUTION)

A REGULATORY FRAMEWORK REQUIRES ALSO... TRANSPARENT AND SCIENTIFICALLY BASED REVIEWING AND DECISION MAKING PROCESSES APPROPRIATE MEANS TO ALLOW THE PARTICIPATION OF ALL STAKEHOLDERS THROUGHOUT SOCIETY

HOW ARE GMOS REGULATED? THE PRODUCT RATHER THE TECHNIQUE IS REGULATED (THE GENETIC ENGINEERING METHODS ARE NOT THE OBJECT OF THE REGULATION) –NOTE: THE PRODUCT (THE GMO WITH THE INSERTED DNA) MAY INCLUDE IN THE GENETIC CONSTRUCT SOME ELEMENTS DERIVED FROM THE PROCESS. IN THIS CASE THEY HAVE TO BE CONSIDERED

SOME BIOSAFETY CRITERIA CAN BE GENERAL REVIEWS SHOULD BE DONE: –ON A CASE BY CASE BASIS: GENERIC CRITERIA (ANALOGIES WITH SIMILAR EVENTS OR PLANTS ARE NOT CONVENIENT) –ALLOWING FOR A STEP BY STEP INCREASE IN AGROECOSYSTEM AREA –ON A INDEPENDENT WAY (AGROECOSYSTEMS ARE DIFFERENT IN DIFFERENT COUNTRIES)

WHAT ELEMENTS ARE CONSIDERED IN THE DECISION MAKING PROCESS?  THE RESULTS OF THE RISK ANALYSIS REVIEW AND ACTIONS:  ASSESSMENT  MANAGEMENT  COMMUNICATION  THE REGULATORY FRAMEWORK  NATIONAL PRIORITIES  THE COUNTRY’S DEVELOPMENT STRATEGIES (LONG TERM DEVELOPMENT AREAS)  PUBLIC POLICIES

HOWEVER, THE DECISION MAKING PROCESS IS NOT SO SIMPLE: OTHER FACTORS ARE ALSO CONSIDERED  IMPACTS ON INTERNATIONAL TRADE (WILL WE BE ABLE TO REACH NEW MARKETS? WILL APROVAL OF A PARTICULAR GMO AFFECT THE ACCEPTANCE BY IMPORTERS? ARE THERE NEW COMPETITORS TO REPLACE OUR SHARE?  SOCIO - ECONOMIC IMPACTS : WILL THE LEVEL OF ADOPTION AFFECT THE BIIOLOGICAL DIVERSITY WHICH WE WISH TO PRESERVE? WILL THE NEW VARIETIES ACCESIBLES FOR SMALL FARMERS?

DECISION MAKING MUST ALSO CONSIDER PUBLIC PERCEPTION (NOT A TECHNICAL ISSUE)  WILL CONSUMERS ACCEPT GMO-DERIVED FOOD? THIS IS NOT A SIMPLE QUESTION. IT DEPENDS ON: - THE LEVEL AND QUALITY OF CONSUMERS INFORMATION - THEIR ATTITUDE TOWARDS NEW TECHNOLOGIES AFFECTING TRADITIONAL FOODS - CULTURAL FACTORS, ETC.

DECISION MAKING STILL DEPENDS OF SOME ADDITIONAL FACTORS  SCIENTIFIC CAPACITY: RISK ANALYSIS IS A SCIENTIFIC BASED PROCESS.  INTERNATIONAL TREATIES: GMO TRADE IS REGULATED BY INTERNATIONAL AGREEMENTS, CONVENTIONS AND CODES OF CONDUCT, WHICH HAVE IMPACT ON TRADE (CARTAGENA PROTOCOL, BDC, SPS, IPPC, OMC)

ARGENTINA REGULATORY FRAMEWORK  THREE STEPS PROCESS 1. Environmental Risk Assessment CONABIA 2. Food Safety Assessment SENASA (Food safety Agency) 3. Impact on international trade DNMA (Agrifood Markets)

1. ENVIRONMENTAL RISK ASSESSMENT TWO PHASES: 1.1. FIRST PHASE. GREENHOUSE AND FIELD TRIAL RELEASE TESTS (APPLICATION WITH 150 QUESTIONS)

1.2. SECOND PHASE. SUBMISSION OF COMPREHENSIVE DOSSIER (WITH ALL SUPPORTING DATA) WITH RESULTS AND STUDIES, ALLOWS GRANTING RELEASE PERMITS WITH LESS INFORMATION REQUIREMENTS, FOR LARGE PLANTINGS (E.G., SEED INCREASE, EXPORTS). NOT A COMMERCIALIZATION PERMIT

EXPRESSION OF THE NEW PHENOTYPE CONSISTS IN THE COMPARISON OF THE GMO WITH THE CLOSEST NON-GMO COUNTERPART IT SHOULD CONFIRM THAT: THE GMO ONLY EXPRESSES THE CHANGES INTENTIONALLY INTRODUCED THROUGH THE GENETIC MODIFICATION THE RISKS ASSOCIATED TO THE MODIFICATION ARE ACCEPTABLE AND/OR MANAGEABLE

SOME SELECTED FEATURES OF THE GMO ARE SPECIALLY RELEVANT BIOLOGY OF REPRODUCTION AND SURVIVAL TRAITS AFFECTING ADAPTATION TO DIVERSE STRESSES PROXIMATE COMPOSITION LEVELS OF NATURAL TOXICS, ALLERGENS AND ANTINUTRITIONAL FACTORS

CHARACTERISTICS RELATED TO THE AGRICULTURAL PRACTICES OF THE NEW CROP THE GROWING AREAS: ARE THEY THE SAME AS TODAY OR THE MODIFICATION WILL ALLOW THE EXPANSION TO NEW AREAS? ANY CHANGES IN AGRICULTURAL PRACTICES? CROP ROTATION WILL BE AFFECTED? HOW VOLUNTARY PLANTS WILL BE CONTROLLED? HOW RESISTANCE MANAGEMENT (INSECTS, WEEDS) SHOULD BE IMPLEMENTED?

A CRUCIAL POINT: POTENTIAL INTERACTIONS WITH OTHER PLANTS ARE INTERACTIONS WITH OTHER ORGANISMOS TO BE EXPECTED? IN THE GROWING AREAS, ARE THERE PLANTS WITH WHICH THE GM PLANT IS ABLE TO CROSS? IS OUTCROSSING POSSIBLE? ARE INTERACTIONS WITH WILD RELATIVES TO BE EXPECTED

WILD RELATIVES COULD PRESENT SPECIAL PROBLEMS THEY MAY HAVE WEED CHARACTERISTICS IN AGROECOSYSTEMS THEY MAY BE INVASIVE TO UNDISTURBED, “NATURAL” ECOSYSTEMS UNINTENDED (AND UNDESIRABLE) GENE FLOW MAY OCCUR THE REPRODUCTIVE ABILITY OF THE WILD RELATIVE MAY BE INCREASED THE WILD RELATIVE MAY ACQUIRE A SELECTIVE ADVANTAGE (DUE TO A SELECTION (PRESSURE)

POTENTIAL UNINTENDED EFFECTS ON OTHER ORGANISMOS SHOULD BE CONSIDERED SOME UNDESIRED EFFECTS: - THE EXPRESSION OF A TOXIN OR OTHER PRODUCT WHICH MAY POTENTIALLY AFFECT THE METABOLISM, GROW, DEVELOPMENT OR REPRODUCTION OF ANIMALS, PLANTS OR MICROORGANISMS - EFFECS ON NON-TARGET ORGANISMS (BENEFICIAL, PREDATORS, POLINIZERS, BIOLOGICAL CONTROL ORGANISMS, PARASITES, SYMBIONTS, MYCORHIZAE)

POTENTIAL UNINTENDED EFFECTS OF THE CROP ON HUMAN HEALTH - PHYSICAL CONTACT (FARMERS) - FURTIVE CONSUMPTION - ARE THERE NEW TOXINS, ALLERGENS OR IRRITANTS TO WHICH THE FARMERS MAY BE EXPOSED?

THE RESULTS OF PHENOTYPIC EXPRESSION ANALYSIS WILL INDICATE POTENTIAL IMPACTS WHICH ARE TO BE EXPECTED FROM THE GMO RELEASE RESULTS MAY BE: - NON SIGNIFICANT - ACCEPTABLE, CONTROLLABLE - NON ACCEPTABLE THEY WIL BE THE BASIS FOR THE DECISSION MAKING PROCESS

MOLECULAR GENETICS CHARACTERIZATION

DATA REQUIREMENTS ARE COMPREHENSIVE AND COMPLEX THE TRANSFORMATION SYSTEM: - THE METHOD - THE GENETIC MATERIAL POTENTIALLY INTRODUCED INTO THE PLANT GENOME THE VECTOR: - DONORS (HISTORY OF USE, POTENTIAL TO DO HARM) - GENETIC ELEMENTS (CODING AND NON CODING) - MAP OF RESTRICTION SITES - SEQUENCES USED AS PROBES AND/OR PCR PRIMERS

THE BIOLOGICAL PROPERTIES OF THE NOVEL EXPRESSED PROTEIN IT MUST BE DEMOSTRATED THAT: IT HAS NO POTENTIAL TO CAUSE DISEASE OR HARM TO PLANTS OR OTHER ORGANISMS IS NOT A: KNOWN TOXIC, ALLERGEN, PATHOGENIC FACTOR, IRRITANT

THE STRUCTURAL PROPERTIES OF THE NOVEL EXPRESSED PROTEIN –INSERTED SEQUENCES (FULL, TRUNCATED) –NUCLEOTIDE CHANGES RESULTING IN AMINOACID SEQUENCE MODIFICATIONS –IF SO, EFFECTS OF THESE MODIFICATIONS ON: - POST-TRANSLATIONAL PROCESSING - DOMAINS WHICH ARE CRUCIAL FOR STRUCTURE OR FUNCTION

THE PROTEIN IN THE PLANT - FUNCTION - EXPRESSION IN THE TISSUES, CONSISTENT WITH THEIR CONTROLLING REGULATORY SEQUENCES - EXPRESSION LEVELS (PROTEIN OR RELEVANT mRNA)

SPECIAL CASES - FRAGMENTS OF GENETIC CONSTRUCTS NOT EXPECTED TO BE FUNCTIONAL IN THE PLANT - FULL OR TRUNCATED SEQUENCES OF A SELECTION MARKER UNDER A BACTERIAL PROMOTER CONTROL

WHAT SHOULD BE KNOWN ABOUT THE INSERTED DNA ITS STABILITY, HOW IT IS INHERITED, IF IT MAY BE MOBILIZED IF FULL OR TRUNCATED COPIES HAVE BEEN INSERTED, AND THEIR NUMBER IF NUCLEOTIDE SEQUENCES HAVE BEEN MODIFIED (OR NOT) TO AVOID TRANSLATION OF THEIR MESSENGERS IF THEY CONTAIN ANTISENSE CONSTRUCTS

OTHER DATA NEEDED ON THE INSERTED DNA POSITION AND INTEGRITY OF FUNCTIONAL PROMOTERS PROMOTORS AND OTHER REGULATORY REGIONS WHICH COULD BE EXPRESSED IN BACTERIA DETAILED ANALYSIS OF THE INSERT AND ITS FLANKING REGIONS IN THE PLANT GENOME SEQUENCES OF PUTATIVE PEPTIDES EXPRESSED BY READ-THROUGH AND/OR GENERATION OF OPEN READING FRAMES

RISK MANAGEMENT

CROP CONTAINMENT PRACTICES: –PHYSICAL (CAGES, SLOPE, FLOWERES BAGGING) –SPACIAL (ISOLATION DISTANCES) –PHENOLOGIAL (DIFFERENT FLOWERING TIMES) –NON-GMO BUFFER ZONES –CONTROL OF EMERGENCY OF VOLUNTARY PLANTS THE NEXT SEASON(S)

OTHER RISK MANAGEMENT PRACTICES RESTRICTIONS TO FURTHER USE OF THE FIELD HYBRID PRODUCTION (PARENTAL TYPE OF THE POLLEN PRODUCER) SPECIALES PROTOCOLS (GEN FLOW CONCERN) SCALE OF RELEASE (AMOUNT OF POLLEN EMISSION) INSPECTIONS SPECIFIC MONITORING (SPECIAL REQUIREMENTS)

RISK COMMUNICATION

HOW TO COMMUNICATE THE RISKS? HOW THE INFORMATION IS TO BE RELEASED TYPE LEVEL DIFUSSION MEDIA CONFIDENTIAL INFORMATION? QUALIFIED OBJECTIONS EFFECTS ON DECISSION MAKING?

OTHER ISSUES CONCERNING COMMUNICAT ION EDUCATION PROGRAMS TARGET AUDIENCES LEVEL MEDIA STRATEGIES PUBLIC PERCEPTION PROGRAMS

IMPLEMENTATION OF THE REGULATORY FRAMEWORK

WHAT IS NEEDED? MECHANISMS FOR THE ASSESSMENT, MANAGEMENT, COMMUNICATION AND MITIGATION OF RISKS APPROPRIATE BUDGET, INFRASTRUCTURE COMPLIANCE VERIFICATION MECHANISMS TRANSPARENCY IN DECISION MAKING

IMPLEMENTATION OF A REGULATORY FRAMEWORK MUST ALSO CONSIDER OTHER OBLIGATIONS INTERNATIONAL COOPERATION (BDC, CP, IPPC, WTO) HARMONIZATION (REGIONAL, INTERNATIONAL) MECHANISMS FOR PUBLIC PARTICIPATION

THE IMPLEMENTATION OF THE REGULATORY FRAMEWORK DOES NOT END WITH THE RISK ASSESSMENT PROCESS POST- COMMERCIALIZATION MONITORING EXAMPLES: INSECTS AND HERBICIDES RESISTANCE MANAGEMENT LONG TERM EFFECTS

THERE ARE ALSO LEGAL AND TECHNICAL REQUIREMENTS GUIDELINES, WELL DEFINED STRUCTURE OF THE BIOSAFETY SYSTEM RELIABLE PROFESSIONALS

HOW TO CONDUCT THE ASSESSMENTS? THE PROCESS SHOULD BE BASED IN THE BEST AND CURRENT SCINTIFIC INFORMATION MECHANISM SHOULD BE IMPLEMENTED FOR THE AWARENESS AND USE OF NEW INFORMATION WHEN NEEDED